Amkardia s.r.o.

At Amkardia s.r.o. in Brno-Stred, clinical research focuses on cardiovascular diseases, with studies centered on atherosclerotic heart and blood vessel disease and atrial fibrillation. These trials are designed to assess new ways to reduce major heart and vascular complications and improve protection against stroke and systemic embolism.

• Evaluating a new approach for people with atherosclerotic cardiovascular disease whose current treatment is not sufficiently effective
• Studying whether a treatment can better prevent stroke and systemic embolism in atrial fibrillation
• Comparing safety and overall benefit in patients at risk for serious cardiovascular events

The site’s work in cardiology is aimed at improving treatment effectiveness, lowering bleeding and clotting risks, and supporting better long-term outcomes for patients with high-risk heart and vessel conditions.